Xequel Bio

About Xequel Bio

Xequel Bio is a clinical-stage biopharmaceutical company transforming its proprietary aCT1 peptide technology to develop drugs that revolutionize how the body responds to injury. The company focuses on applications in dermatology, ophthalmology, and pulmonology, with formulations including topical gels, ophthalmic solutions, and aerosolized therapies. Headquartered in Fort Worth, Texas with research and development activities in Mount Pleasant, South Carolina, Xequel Bio aims to rebuild healthy tissue and accelerate re-epithelialization through stabilized tissue integrity.